Category: Tuberculosis
Global Tuberculosis
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
TB Diagnostic Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global TB diagnostic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global TB ... Read More
-
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033
... Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La ... Read More
-
2024 Global Tuberculosis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
Infectious Disease Diagnostics
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion ... Read More
-
2024 Global Forecast for Tuberculosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Tuberculosis (Tb) Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global VPM1002 (Tuberculosis BCG Based Vaccine) Market Research Report 2024(Status and Outlook)
... parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of ... Read More
-
Tuberculosis Therapeutics
... at a CAGR of 2.7% over the analysis period 2023-2030. Active TB Therapeutics, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end ... Read More
-
Tuberculosis Testing
... at a CAGR of 5.1% over the analysis period 2023-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$714.5 Million by the end of ... Read More
-
Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024(Status and Outlook)
... risk of developing TB. The Global BCG Vaccine for Tuberculosis (TB) Market Size was estimated at USD 397.17 million in 2023 and is projected to reach USD 550.75 million by 2029, exhibiting a CAGR of ... Read More
-
Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Instruments and Devices, Assays & Reagents, Services & Software), By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2019-2029F
... Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2019-2029F Global Respiratory Diagnostics Market was valued ... Read More
-
Global Tuberculosis (TB) Diagnostics Competitive Landscape Professional Research Report 2024
... (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Competitive Landscape Professional Research Report 2024
... the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis ... Read More
-
Global Tuberculosis Vaccine Treatment Competitive Landscape Professional Research Report 2024
... produce antibodies and cellular immune responses against the tuberculosis bacilli. This vaccine is usually given after birth or in early childhood to prevent the development and spread of TB. Although tuberculin vaccine is a routine ... Read More
-
Global Tuberculosis (TB) Detection Competitive Landscape Professional Research Report 2024
... methods are used for TB detection depending on the suspected type of infection and the resources available. Common TB detection methods include tuberculin skin tests (TST), also known as Mantoux tests, where a small amount ... Read More
-
Tuberculosis (TB) Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... at USD 2.17 billion in 2023, and the market is now projected to grow from USD 2.28 billion in 2024 to USD 3.58 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period ... Read More
-
Global Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, ... Read More
-
Pulmonary Tuberculosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Analysis and Forecast 2024-2030
... the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030
... other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about ... Read More
-
Live Attenuated Vaccines Market - By Vaccine Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Age Group, Mode of Administration, Indication (Tuberculosis, Measles, Rotavirus), End-use - Global Forecast (2024 Â 2032)
... vaccines market will witness 10.4% CAGR from 2024 to 2032. The long-term protection provided by live vaccines against diseases has led to their widespread use besides their ability to stimulate a strong immune response, further ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Tuberculosis Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Active TB, Latent TB), By Therapy (First-Line Therapy, Second-Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Tuberculosis Therapeutics market size is poised to register 5.24% growth from 2024 to 2030, presenting significant growth prospects ... Read More
Research Assistance
